日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world study of use patterns and clinical outcomes for patients with myelodysplastic syndrome initiating oral decitabine and cedazuridine or intravenous/subcutaneous hypomethylating agents

一项针对接受口服地西他滨和西达唑啶或静脉/皮下注射去甲基化药物治疗的骨髓增生异常综合征患者的真实世界研究,旨在评估其用药模式和临床疗效。

Zeidan, Amer M; Zhao, Ruizhi; Tepsick, Jon G; Lan, Ziyu; Salimi, Tehseen

Goserelin 3-month depot shows non-inferiority to the monthly formulation in U.S. patients with premenopausal breast cancer: a real-world evidence study

戈舍瑞林3个月缓释剂在美国绝经前乳腺癌患者中显示出不劣于每月一次的制剂:一项真实世界证据研究

McCann, Kelly E; Osman, Noran; Cannon, Joan; Brent, Lonnie; Wang, Yuexi; Tepsick, Jon; Mandora, Prithviraj Vikramsinh; Miller, Vincent; Martin, Nancy; Kaklamani, Virginia G

A retrospective analysis of treatment patterns, overall survival, and real-world disease-free survival in early-stage non-small cell lung cancer following complete resection

对早期非小细胞肺癌完全切除术后的治疗模式、总生存期和真实世界中的无病生存期进行回顾性分析

Hu, Xiaohan; Chirovsky, Diana; Walker, Mark S; Wang, Yuexi; Kaushiva, Alpana; Tepsick, Jon; Samkari, Ayman

Improving Real-World Mortality Data Quality in Oncology Research: Augmenting Electronic Medical Records With Obituary, Social Security Death Index, and Commercial Claims Data

提高肿瘤研究中真实世界死亡率数据的质量:利用讣告、社会保障死亡索引和商业索赔数据扩充电子病历

Shao, Ping; Tepsick, Jon G; Walker, Brigham; Ray, Herman E